U.S. Physical Therapy Reports Strong 2025 Operational Growth, Raises Dividend, Despite GAAP EPS Decline

summarizeSummary

U.S. Physical Therapy reported strong 2025 revenue and operating income growth, increased its dividend, and continued strategic expansion, though GAAP EPS declined due to a non-cash accounting adjustment.

check_boxKey Events

• Strong 2025 Financial Performance

  Net revenue increased 16.3% to $781.0 million, and operating income rose 37.6% to $86.7 million for the year ended December 31, 2025.

• GAAP EPS Decline Due to Accounting Adjustment

  Basic and diluted EPS decreased to $1.42 from $1.84, primarily due to a $24.5 million non-cash revaluation of redeemable non-controlling interests.

• Dividend Increase Announced

  The Board of Directors raised the quarterly dividend from $0.45 per share to $0.46 per share, effective for the first quarter of 2026, payable on April 10, 2026.

• Share Repurchase Program Activity

  The company repurchased 81,322 shares of common stock for $5.6 million in Q4 2025, with $19.4 million remaining under the authorized $25.0 million program.

auto_awesomeAnalysis

U.S. Physical Therapy delivered robust revenue and operating income growth in 2025, driven by strategic acquisitions and partnerships. While GAAP EPS decreased due to a significant non-cash revaluation of redeemable non-controlling interests, non-GAAP metrics like Adjusted EBITDA showed strong improvement. The company also demonstrated commitment to shareholder returns through a dividend increase and a share repurchase program. Investors should focus on the underlying operational strength and strategic expansion, understanding the accounting impact on GAAP EPS.